Sign in

    Kimberly-Clark Corp (KMB)

    You might also like

    Kimberly-Clark Corporation is a global company specializing in the manufacturing and marketing of products made from natural or synthetic fibers and materials. The company operates through three main business segments, offering a variety of personal care, consumer tissue, and professional products. Kimberly-Clark's product portfolio includes well-known brands such as Huggies, Kleenex, and Scott, which hold leading positions in their respective markets .

    1. Personal Care - Manufactures and markets disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, and reusable underwear under brands like Huggies, Pull-Ups, Kotex, and Depend .
    2. Consumer Tissue - Offers facial and bathroom tissue, paper towels, and napkins under brands like Kleenex, Scott, and Cottonelle .
    3. K-C Professional - Provides wipers, tissue, towels, and personal protective equipment with brands including Kleenex, Scott, and WypAll .
    NamePositionExternal RolesShort Bio

    Michael D. Hsu

    ExecutiveBoard

    Chairman of the Board and CEO

    Board Member at McDonald's Corporation; Board Member at Texas Instruments

    Joined KMB in 2012; became CEO in 2019 and Chairman in 2020; previously held leadership roles at Kraft Foods and Heinz.

    View Report →

    Craig Slavtcheff

    Executive

    Chief Research and Development Officer

    None

    Joined KMB in 2024; previously EVP and Chief R&D Officer at Campbell Soup Company.

    Ehab Abou-Oaf

    Executive

    President, International Family Care and Professional

    Board Member at American University in Cairo; Board Member at Singapore American School

    Joined KMB in 2020; previously held leadership roles at Mars, Inc. and Procter & Gamble.

    Grant B. McGee

    Executive

    Senior Vice President, General Counsel, and Corporate Secretary

    None

    Rejoined KMB in 2024; previously held legal leadership roles at American Airlines and KMB.

    Jeffrey Melucci

    Executive

    Chief Business, Strategy and Transformation Officer

    None

    Joined KMB in 2013; held various leadership roles, including Chief Business Development and Legal Officer.

    Katy Chen

    Executive

    President, International Personal Care

    None

    Joined KMB in 2009; previously led KMB's China operations and digital transformation initiatives.

    Nelson Urdaneta

    Executive

    Senior Vice President and CFO

    None

    Joined KMB in 2022; previously held senior finance roles at Mondelēz International and Ryder System, Inc.

    Patricia Corsi

    Executive

    Chief Growth Officer

    None

    Joined KMB in 2024; previously Chief Marketing, IT, and Digital Officer at Bayer Consumer Health.

    Russell Torres

    Executive

    President, North America

    None

    Joined KMB in 2020; previously held leadership roles at Newell Brands and Mondelēz International.

    Sandra R.A. Karrmann

    Executive

    Senior Vice President and Chief People Officer

    None

    Joined KMB in 2020; previously held HR leadership roles at Tenet Healthcare and United Surgical Partners International.

    Tamera Fenske

    Executive

    Senior Vice President and Chief Supply Chain Officer

    None

    Joined KMB in 2022; previously held senior supply chain roles at 3M Company.

    Zackery Hicks

    Executive

    Chief Digital and Technology Officer

    Board Member at Signet Jewelers Ltd

    Joined KMB in 2022; previously held digital leadership roles at Toyota Motor North America.

    Christa S. Quarles

    Board

    Director

    CEO of Alludo; Board Member at Affirm Holdings, Inc.

    Joined KMB's board in 2016; former CEO of OpenTable and leader in digital transformation.

    Deeptha Khanna

    Board

    Director

    EVP and Chief Business Leader, Personal Health at Royal Philips

    Joined KMB's board in 2023; previously held leadership roles at Johnson & Johnson and Procter & Gamble.

    Deirdre A. Mahlan

    Board

    Director

    Interim CEO and Chairperson of The Duckhorn Portfolio; Board Member at Haleon plc

    Joined KMB's board in 2021; former President of Diageo North America and CFO of Diageo plc.

    Dunia A. Shive

    Board

    Director

    Board Member at DallasNews Corporation, Main Street Capital Corporation, and Trinity Industries

    Joined KMB's board in 2019; former CEO of Belo Corp.

    Jaime A. Ramirez

    Board

    Director

    None

    Joined KMB's board in 2021; former EVP and President, Global Tools & Storage at Stanley Black & Decker.

    John W. Culver

    Board

    Director

    Board Member at Columbia Sportswear Company; Director at The Mission Continues

    Joined KMB's board in 2020; former Group President at Starbucks Corporation.

    Joseph Romanelli

    Board

    Director

    President of Human Health International at Merck & Co., Inc.

    Joined KMB's board in 2024; former CEO of JiXing Pharmaceuticals and leader in global biopharmaceutical operations.

    Mae C. Jemison

    Board

    Director

    Founder of The Jemison Group; Principal for the 100 Year Starship Project

    Joined KMB's board in 2002; former NASA astronaut and leader in science and technology innovation.

    Mark T. Smucker

    Board

    Director

    Chair of the Board, President, and CEO of The J.M. Smucker Company

    Joined KMB's board in 2019; leads The J.M. Smucker Company and has extensive experience in branded consumer goods.

    S. Todd Maclin

    Board

    Director

    Board Member at Trinity Industries; Board Advisor at Cyber Defense Labs

    Joined KMB's board in 2019; retired after a 37-year career at JPMorgan Chase & Co.

    Sherilyn S. McCoy

    Board

    Director

    Board Member at Stryker Corporation

    Joined KMB's board in 2018; former CEO of Avon Products and Vice Chairman at Johnson & Johnson.

    Sylvia M. Burwell

    Board

    Director

    President of American University; Board Member at GuideWell Mutual Holding Corporation

    Joined KMB's board in 2022; former U.S. Secretary of Health and Human Services and Director of the White House Office of Management and Budget.

    1. "You've noted that the exit from private label businesses will create a headwind of about 2% in 2025 due to ceasing production for a large club private label diaper business in the U.S. ; with this significant impact on revenue, what specific strategies are you implementing to offset this loss and drive growth in your branded products?"

    2. "Given that your gross margin has expanded year-to-date and is tracking ahead of pre-COVID levels , but you're facing soft organic sales and potential need to increase promotions due to consumer pressures, how sustainable are these margin levels, and what risks do you see to maintaining them in the coming quarters?"

    3. "Despite implementing your new organizational structure as of October 1 , you expect category growth to decelerate to the lower end of your long-term range ; how will this restructuring help drive the intended growth, and what challenges do you anticipate in achieving your goals?"

    4. "Amid significant organizational changes and market volatility, including demand deceleration in key regions and channels , how has your visibility into business performance and forecasting accuracy been affected, and what measures are you taking to improve it?"

    5. "With innovations like Skin Essentials reportedly exhibiting high cannibalization rates , how do you assess the effectiveness of such products in driving net incremental growth versus merely shifting sales within your portfolio, and what strategies are in place to ensure innovation leads to market share gains?"

    Program DetailsProgram 1
    Approval DateJanuary 22, 2021
    End Date/DurationN/A
    Total additional amount$5 billion
    Remaining authorization amount33,695,323 shares
    DetailsAllows repurchase of 40 million shares
    YearAmount Due (Millions)Debt TypeInterest Rate (%)% of Total Debt
    20244U.S. commercial paper and/or similar short-term debtN/A0.05% = (4 / 7,500) * 100
    2024569Debt payable within one year (includes short-term and current portion of long-term debt)N/A7.6% = (569 / 7,500) * 100
    N/A6,882Long-term debtN/A91.8% = (6,882 / 7,500) * 100
    NameStart DateEnd DateReason for Change
    Deloitte & Touche LLP1928PresentCurrent auditor

    Notable M&A activity and strategic investments in the past 3 years.

    CompanyYearDetails

    Thinx Inc.

    2023

    Kimberly-Clark increased its ownership in Thinx Inc. by acquiring additional common securities for $48 million in cash during the first half of 2023, raising its stake to 70%; this acquisition, which followed the initial 2022 majority investment totaling $181 million, was executed as an equity transaction with consolidation under the Personal Care segment.

    Recent developments and announcements about KMB.

    Earnings

    • New Earnings (Q4 2024)

      ·
      Jan 28, 2025, 5:20 PM

      Kimberly-Clark eyes 2–3% volume and mix growth in 2025, with 5% productivity gains and $200M in SG&A savings powering operating margin growth – but gross margin expansion will slow on muted pricing.

      View full earnings summary →

    Press Releases

    • Press Release

      ·
      Feb 12, 2025, 1:49 AM

      Kimberly-Clark has raised its quarterly dividend by 3.3% to $1.26 per share, marking the 53rd consecutive year of dividend increases. The dividend will be paid on April 2, 2025, to shareholders of record on March 7, 2025.

      View full press release →